Herman H. Stein

1.6k total citations
59 papers, 1.3k citations indexed

About

Herman H. Stein is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Herman H. Stein has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 19 papers in Organic Chemistry. Recurrent topics in Herman H. Stein's work include Renin-Angiotensin System Studies (22 papers), Receptor Mechanisms and Signaling (15 papers) and Chemical Synthesis and Analysis (11 papers). Herman H. Stein is often cited by papers focused on Renin-Angiotensin System Studies (22 papers), Receptor Mechanisms and Signaling (15 papers) and Chemical Synthesis and Analysis (11 papers). Herman H. Stein collaborates with scholars based in United States, United Kingdom and Canada. Herman H. Stein's co-authors include Jerome Cohen, Jacob J. Plattner, Hollis D. Kleinert, Saul H. Rosenberg, William R. Baker, Thomas J. Perun, Jay R. Luly, Anthony K. L. Fung, Kenneth P. Spina and Hing L. Sham and has published in prestigious journals such as Science, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Herman H. Stein

57 papers receiving 1.2k citations

Peers

Herman H. Stein
Samuel Chackalamannil United States
Michael Czarniecki United States
Derek R. Buckle United Kingdom
Steven E. Hall United States
Philippe R. Bovy United States
Jeremy J. Edmunds United States
Stephen E. de Laszlo United States
Samuel Chackalamannil United States
Herman H. Stein
Citations per year, relative to Herman H. Stein Herman H. Stein (= 1×) peers Samuel Chackalamannil

Countries citing papers authored by Herman H. Stein

Since Specialization
Citations

This map shows the geographic impact of Herman H. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman H. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman H. Stein more than expected).

Fields of papers citing papers by Herman H. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herman H. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman H. Stein. The network helps show where Herman H. Stein may publish in the future.

Co-authorship network of co-authors of Herman H. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Herman H. Stein. A scholar is included among the top collaborators of Herman H. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herman H. Stein. Herman H. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shen, David S. Garvey, Jerry D. Cohen, Herman H. Stein, & Saul H. Rosenberg. (1998). Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: Syntheses and evaluation. Bioorganic & Medicinal Chemistry Letters. 8(8). 891–896. 5 indexed citations
2.
Boyd, Steven A., Anthony K. L. Fung, William R. Baker, et al.. (1994). Nonpeptide Renin Inhibitors with Good Intraduodenal Bioavailability and Efficacy in Dog. Journal of Medicinal Chemistry. 37(19). 2991–3007. 29 indexed citations
3.
Rosenberg, Saul H., Kenneth P. Spina, Herman H. Stein, et al.. (1994). Renin inhibitors: C-terminal oxetanes as potent transition-state mimics. Bioorganic & Medicinal Chemistry. 2(9). 927–937. 4 indexed citations
4.
Rosenberg, Saul H., Kenneth P. Spina, Keith W. Woods, et al.. (1993). Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides. Journal of Medicinal Chemistry. 36(4). 449–459. 46 indexed citations
6.
Wessale, Jerry L., Samuel V. Calzadilla, Steven A. Boyd, et al.. (1993). Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs. Journal of Cardiovascular Pharmacology. 22(4). 644–652. 8 indexed citations
7.
Baker, William R., Anthony K. L. Fung, Hollis D. Kleinert, et al.. (1992). Nonpeptide renin inhibitors employing a novel 3-aza (or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement. Journal of Medicinal Chemistry. 35(10). 1722–1734. 12 indexed citations
8.
Martin, Stephen F., Richard E. Austin, Christopher J. Oalmann, et al.. (1992). 1,2,3-Trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors. Journal of Medicinal Chemistry. 35(10). 1710–1721. 72 indexed citations
9.
Boyd, Steven A., Anthony K. L. Fung, William R. Baker, et al.. (1992). C-Terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties. Journal of Medicinal Chemistry. 35(10). 1735–1746. 27 indexed citations
10.
Kleinert, Hollis D., William R. Baker, & Herman H. Stein. (1991). Renin Inhibitors. Advances in pharmacology. 22. 207–250. 14 indexed citations
11.
Rosenberg, Saul H., Hollis D. Kleinert, Herman H. Stein, et al.. (1991). Design of a well-absorbed renin inhibitor. Journal of Medicinal Chemistry. 34(1). 469–471. 29 indexed citations
12.
Rosenberg, Saul H., Joseph F. Dellaria, Dale J. Kempf, et al.. (1990). Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site. Journal of Medicinal Chemistry. 33(6). 1582–1590. 17 indexed citations
13.
Giardina, William J., et al.. (1990). Intraocular Pressure Lowering Effects of the Renin Inhibitor ABBOTT-64662 Diacetate in Animals. Journal of Ocular Pharmacology and Therapeutics. 6(2). 75–83. 31 indexed citations
14.
Dellaria, Joseph F., Robert G. Maki, Herman H. Stein, et al.. (1990). New inhibitors of renin that contain novel phosphostatine Leu-Val replacements. Journal of Medicinal Chemistry. 33(2). 534–542. 96 indexed citations
15.
Kempf, Dale J., et al.. (1990). Renin inhibitors based on dipeptide analogs. Incorporation of the hydroxyethylene isostere at the P2/P3 sites. Journal of Medicinal Chemistry. 33(1). 371–374. 12 indexed citations
16.
Plattner, Jacob J., Patrick A. Marcotte, Hollis D. Kleinert, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability. Journal of Medicinal Chemistry. 31(12). 2277–2288. 54 indexed citations
17.
Sham, Hing L., Giorgio Bolis, Herman H. Stein, et al.. (1988). Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogs of angiotensinogen. Journal of Medicinal Chemistry. 31(2). 284–295. 36 indexed citations
18.
Kempf, Dale J., et al.. (1987). Renin inhibitors based on novel dipeptide analogs. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond. Journal of Medicinal Chemistry. 30(11). 1978–1983. 15 indexed citations
19.
Bolis, Giorgio, Anthony K. L. Fung, Jonathan Greer, et al.. (1987). Renin inhibitors. Dipeptide analogs of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. Journal of Medicinal Chemistry. 30(10). 1729–1737. 24 indexed citations
20.
Fesik, Stephen W., Jay R. Luly, Herman H. Stein, & Nwe Y. BaMaung. (1987). Amide proton exchange rates of a bound pepsin inhibitor determined by isotope-edited proton NMR experiments. Biochemical and Biophysical Research Communications. 147(3). 892–898. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026